Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101
- Citation:
- J Clin Oncol vol 28 (29) 4500-4506
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Pharmas:
- Grants:
- CA33601, U10 CA031946, U10 CA033601, R21 CA101332, R21CA101332, CA31946
- Corr. Author:
- Authors:
- Thomas S. Lin Kathleen A. Donohue John C. Byrd Margaret S. Lucas Eva E. Hoke Elizabeth M. Bengtson Kanti R. Rai James N. Atkins Brian K. Link Richard A. Larson
- Networks:
- Study
- CALGB-10101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Hema5, Hema6, Hema7, Original Reports, Hematologic Malignancies